ViiV Healthcare Investigator-Sponsored Research (ISR) Programme
ViiV Healthcare (VH) is an independent, global specialist HIV company established in 2009 with the commitment
to deliver innovative new options for the care and treatment of people living with HIV/AIDS. As part of the
commitment, we recognize the valuable role that our support of investigator-sponsored research (ISR) plays in
fulfilling this mission. An investigator-sponsored study is a research effort where the sponsor of the work is
the investigator, healthcare institution, or some form of medical network external to VH and is seeking our
support to conduct the work. Depending on the type of research, this support may include any of the following:
providing drug product or substance; providing funding; participating in collaboration to develop and conduct a
study of mutual scientific and/or clinical interest.
VH only supports ISR that has a legitimate scientific purpose. The decision to support a study proposal is
based on the importance of the research objectives to medical science or patient care, the scientific rationale
for the proposed methodology, and the ability of the study sponsor to deliver a high-quality ethical study.
VH does not support ISR in order to reward healthcare professionals for using, purchasing, recommending, or
prescribing VH products or to persuade them to do so by supporting
VH expects that when submitting your proposal, you will agree to publish your results in a timely fashion and
you confirm the Sponsoring entity you represent will agree to grant ViiV -as a minimum- an indefinite
non-exclusive license of all data, information and intellectual property resulting from the Study and an option
to negotiate an exclusive license.
ViiV ISR adhere to local laws, regulations, industry codes, and applicable VH written standards including local country-specific written standards. In the case of conflicting requirements, the one which is most strict is followed.
This ViiV ISR portal currently includes three sections based on the type of study you are proposing and
subsequently tracking. Each type has specific information and review processes which allow VH to optimize our
response to your proposal and the tracking of the subsequent study activities.
VH accepts study proposals from Investigators in two ways:
Pure Substance Requests/Studies
New ISS and RFP
Requests/Studies
Collaborative
Requests/Studies
All Safety Reporting must be conducted as per your study agreement. If you need to report a suspected side effect for a ViiV Healthcare medicine that is not part of your study, please click the following.
Report a side effect
To report a suspected side effect, please use the online reporting form below. This facility is provided under our service agreement with GlaxoSmithKline (GSK), so please choose ‘ViiV Healthcare medicines’ from the drop-down product list on the form. In North America, you can report a side effect via the GSK Response Center at 1-888-825-5249, Monday-Friday, 8am - 8pm ET.